Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
111 hedge funds and large institutions have $225M invested in Arena Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 16 closing their positions.
26% more call options, than puts
Call options by funds: $1.17M | Put options by funds: $931K
11% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 35
8% less capital invested
Capital invested by funds: $245M → $225M (-$19.6M)
8% less funds holding
Funds holding: 121 → 111 (-10)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Top Buyers
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$19.9M |
| 2 |
Millennium Management
New York
|
-$3.11M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.98M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.95M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$1.56M |
ARNA Hedge Fund Activity: Q1 2016 in Review
111 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2016, worth a combined $225M — down 8% from $245M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ARNA and 7 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 39 added.
The largest buyer was Wellington Management Group, adding an estimated $2.79M. The largest seller was Camber Capital Management, exiting entirely with an estimated $19.9M sold.
- 111 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2016, down from 121 in Q4 2015.
- Funds reported $225M of Arena Pharmaceuticals Inc stock for Q1 2016, down 8% quarter-over-quarter.
- 7 funds opened new Arena Pharmaceuticals Inc positions in Q1 2016 and 16 closed out, a net change of -9 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2016 was Wellington Management Group, an estimated $2.79M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2016 was Camber Capital Management, an estimated $19.9M sold.
Based on aggregated 13F filings for Q1 2016.